Clinical trial

Evaluation of AZD8154 Concentrations in Blood

NCT04480879

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2020-07-17

PhasePHASE1

Study timeline

Study start (actual)2020-07-17Date precision: day

Registry last updated2021-08-24

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Asthmaunresolved

Interventions

AZD8154 nebuliserDRUG

AZD8154 Monodose DPI presented in capsulesDRUG

AZD8154 Placebo Monodose DPI presented in capsulesDRUG

Sponsors & collaborators

AstraZenecalead sponsor

Parexelcollaborator

Mapped research locations

BerlinGermany1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04480879 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.